United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance
Go back to United Therapeutics Corp (UTHR) Reports Q4 EPS of $0.79, Reaffirms FY12, FY13 Guidance| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 529.14 +10.87 (2.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $518.27 | 52 Week High | $164.04 | |||
| Open | $525.47 | 52 Week Low | $97.52 | |||
| Day High | $535.77 | P/E | 96.73 | |||
| Day Low | $522.04 | EPS | $5.47 | |||
| Volume | 432,111 | |||||
